EUVIMEDDescubrir EUVIMED
Crossref

Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of IRG1

Yang Xiang, Ge Kuang, Xia Gong, Huang Xie, Yan Lin, Xijian Zhang, Zhongpei Chen, Jingyuan Wan iD, Zhenhan Li iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.8443 ↗

At a glance

Journal article in Phytotherapy Research, 2025. Written by Yang Xiang and 8 co-authors. Institution: Department of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China. Major MEDLINE topics: Non-alcoholic Fatty Liver Disease, Phenanthrenes. Cited 7 times so far (Crossref); 65 references. Funded by: Chongqing Natural Science Foundation, Chongqing Postdoctoral Innovative Talents Support Program Fund, Chongqing Medical youth top talent project.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, but effective therapeutic drugs are still lacking. Dihydrotanshinone I (DHTS), a natural product isolated from Salvia miltiorrhiza , has been shown to have ameliorative effects on NAFLD. The aim of this study was to investigate the hepatoprotective effect of DHTS on NAFLD and its mechanism. A model of NAFLD and DHTS treatment was established using a Western diet to observe the effect of DHTS on NAFLD, which were detected by immunohistochemical, immunofluorescence, and other experiments. The mechanism was further explored by constructing immune responsive gene 1 (IRG1) knockout mice, RNA sequence, and molecular docking. The results revealed that DHTS significantly improved diet‐induced metabolic disorders in mice, notably alleviating liver inflammation, oxidative stress, and fibrosis. Further analysis revealed that the intervention of DHTS was associated with the activation of IRG1. Subsequent experiments confirmed that IRG1 gene deletion reversed the above protective effects of DHTS in NAFLD. Mechanistically, DHTS enhanced the antioxidant nuclear factor–erythroid 2‐related factor 2 (Nrf2) pathway through IRG1/itaconate and blocked the oxidative stress response in the liver. In addition, DHTS also inhibited the activation of NACHT‐, leucine‐rich repeat (LRR)–, and pyrin domain (PYD)–containing protein 3 (NLRP3) inflammasome via IRG1/itaconate, blocking the inflammatory amplification effect in the liver. The study suggests that DHTS may be a potential drug for the treatment of NAFLD, which exerts protective regulatory effects mainly through the IRG1/itaconate molecular pathway.

Subjects

MeSH terms (MEDLINE)

Non-alcoholic Fatty Liver DiseasePhenanthrenesAnimalsMaleMiceUp-RegulationMice, Inbred C57BLNF-E2-Related Factor 2Mice, KnockoutOxidative StressLiverSalvia miltiorrhizaMolecular Docking SimulationDiet, WesternNLR Family, Pyrin Domain-Containing 3 ProteinFuransQuinones

Author keywords

dihydrotanshinone Iimmune responsive gene 1nonalcoholic fatty liver diseasenuclear factor–erythroid 2‐related factor 2

Substances

dihydrotanshinone INF-E2-Related Factor 2PhenanthrenesNfe2l2 protein, mouseNLR Family, Pyrin Domain-Containing 3 ProteinFuransQuinones

Authors and institutions

  • Department of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
  • Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Medical University, Chongqing, China.
  • Department of Anatomy, Chongqing Medical University, Chongqing, China.

ORCID profiles: Jingyuan Wan, Zhenhan Li

Funding

  • Chongqing Natural Science Foundation
  • Chongqing Postdoctoral Innovative Talents Support Program Fund
  • Chongqing Medical youth top talent project
  • The 4th young talent project of Chongqing Hospital Of Traditional Chinese Medicine
  • Science Health Joint Medical Scientific Research Project of Chongqing

Cite

APA

Xiang, Y., Kuang, G., Gong, X., Xie, H., Lin, Y., Zhang, X., Chen, Z., Wan, J., & Li, Z. (2025). Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of IRG1. Phytotherapy Research. https://doi.org/10.1002/ptr.8443

Vancouver

Xiang Y, Kuang G, Gong X, Xie H, Lin Y, Zhang X, et al. Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of IRG1. Phytotherapy Research. 2025. doi:10.1002/ptr.8443

BibTeX
@article{Xiang2025,
  author = {Xiang, Yang and Kuang, Ge and Gong, Xia and Xie, Huang and Lin, Yan and Zhang, Xijian and Chen, Zhongpei and Wan, Jingyuan and Li, Zhenhan},
  title = {Dihydrotanshinone I Attenuates Diet‐Induced Nonalcoholic Fatty Liver Disease via Up‐Regulation of IRG1},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.8443}
}
Start for free →